Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Science Press Releases.
Press releases published on April 23, 2025
iManage Receives IRAP Assessment within Australian Market
GlobeNewswire
·
April 23, 2025
CHICAGO, April 23, 2025 (GLOBE NEWSWIRE) -- iManage, the company dedicated to Making Knowledge Work™, today announced that the iManage Cloud knowledge work platform has been IRAP assessed, giving Australian governmental agencies and the law firms that do …
CEO of MASORI Therapeutics, Featured in CIO Insightful’s 'The Most Influential Artificial Intelligence Leaders of 2025'
EIN Presswire
·
April 23, 2025
Visionary executive acknowledged for innovative use of AI in transforming legacy pharmaceutical marketing, sales, and engagement strategies HENDERSON, NV, UNITED STATES, April 23, 2025 /EINPresswire.com/ -- Visionary executive acknowledged for …
Imperial Reports Production Update for 2025 First Quarter and Petition Filed Relating to the Mount Polley Tailings Storage Facility Raise
GlobeNewswire
·
April 23, 2025
VANCOUVER, British Columbia, April 23, 2025 (GLOBE NEWSWIRE) -- Imperial Metals Corporation (“Imperial”) (TSX:III) reports copper and gold production for the first quarter 2025 from Mount Polley and Red Chris mines. Imperial’s production was 15.8 million …
الجزيئات البلاستيكية تهدّد أمننا الغذائي..غرينبيس الشرق الأوسط وشمال أفريقيا تدعو إلى معاهدة عالمية طموحة بشأن البلاستيك
EIN Presswire
·
April 23, 2025
دراسة جديدة تحذّر: التلوث البلاستيكي قد يعرّض 400 مليون شخص للجوع خلال العقدين المقبلين بيروت, LEBANON, April 23, 2025 /EINPresswire.com/ -- كشفت دراسة جديدة أن الجزيئات البلاستيكية الدقيقة تُعيق عملية البناء الضوئي لدى النباتات، مما يهدد الإنتاج …
Greenpeace MENA Calls for an Ambitious Plastics Treaty as Microplastics Threaten Global Food Security
EIN Presswire
·
April 23, 2025
New study warns: plastic pollution could leave 400 million people facing hunger in the coming two decades BEIRUT, LEBANON, April 23, 2025 /EINPresswire.com/ -- A startling new study has revealed that microplastics are inhibiting plant photosynthesis, …
Mineralys Therapeutics Announces Publication of Pivotal Phase 2 Advance-HTN Results in the New England Journal of Medicine (NEJM)
GlobeNewswire
·
April 23, 2025
– Significant blood pressure reductions among patients with uncontrolled or resistant hypertension treated with lorundrostat reinforce key role of dysregulated aldosterone in disease onset and progression – – Detailed results from the second pivotal Phase …
Supernus Pharmaceuticals to Announce First Quarter 2025 Financial Results and Host Conference Call and Webcast on May 6, 2025
GlobeNewswire
·
April 23, 2025
ROCKVILLE, Md., April 23, 2025 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, today announced …
Aptose Announces Auditor Not Standing for Re-Appointment
GlobeNewswire
·
April 23, 2025
SAN DIEGO and TORONTO, April 23, 2025 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (TSX:APS), a clinical-stage precision oncology company developing a tuspetinib (TUS) based triple drug frontline therapy to treat patients with …
TransAlta Declares Dividends
GlobeNewswire
·
April 23, 2025
CALGARY, Alberta, April 23, 2025 (GLOBE NEWSWIRE) -- The Board of Directors of TransAlta Corporation (TSX: TA) (NYSE: TAC) declared the following quarterly dividend on its Cumulative Redeemable Rate Reset First Preferred Shares for the period starting from …
Xilio Therapeutics to Present Updated Phase 2 Data for Vilastobart, a Tumor-Activated, Fc-Enhanced Anti-CTLA-4, in Combination with Atezolizumab in Patients with Microsatellite Stable Colorectal Cancer at the 2025 ASCO Annual Meeting
GlobeNewswire
·
April 23, 2025
WALTHAM, Mass., April 23, 2025 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology therapies for people living with cancer, today announced plans to …
[Latest] Global Plastic Pallet Market Size/Share Worth USD 13,591 Million by 2034 at a 89% CAGR: Business Research Industry (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
GlobeNewswire
·
April 23, 2025
Austin, TX, USA, April 24, 2025 (GLOBE NEWSWIRE) -- Business Research Industry has published a new research report titled “Plastic Pallet Market Size, Trends and Insights By Material (High-Density Polyethylene, Low-Density Polyethylene, Polypropylene (PP), …
Brag House Provides Update on Status of Form 10-K Filing and Reiterates Commitment to SEC Compliance Obligations
GlobeNewswire
·
April 23, 2025
NEW YORK, April 23, 2025 (GLOBE NEWSWIRE) -- Brag House Holdings, Inc. (NASDAQ: TBH), a pioneering media-tech platform at the intersection of gaming, college sports, and social interaction, continues to diligently work on its Form 10-K for the fiscal year- …
Palvella Therapeutics Announces Abstract Highlighting the Estimated Diagnosed Prevalence and Annual Incidence of Lymphatic Malformations in the U.S. Accepted for Poster Presentation at the 82nd Annual Meeting of the Society for Investigative Dermatology
GlobeNewswire
·
April 23, 2025
Quantitative analysis of medical claims indicates an estimated 44,553 to 92,967 diagnosed U.S. patients with lymphatic malformations (LMs) with cutaneous involvement Estimates of annual incidence of LMs with cutaneous involvement to be highlighted in the …
Iovance Biotherapeutics Announces Participation in Upcoming Scientific Congresses
GlobeNewswire
·
April 23, 2025
SAN CARLOS, Calif., April 23, 2025 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (TIL) therapies for patients with …
Silvaco Announces Date of First Quarter 2025 Financial Results Conference Call
GlobeNewswire
·
April 23, 2025
SANTA CLARA, Calif., April 23, 2025 (GLOBE NEWSWIRE) -- Silvaco Group, Inc. (Nasdaq: SVCO, “Silvaco”), a provider of TCAD, EDA software, and SIP solutions that enable innovative semiconductor design and digital twin modeling through AI software and …
Corvus Pharmaceuticals to Present New Interim Data from Placebo-Controlled Phase 1 Clinical Trial of Soquelitinib for Atopic Dermatitis on May 8, 2025
GlobeNewswire
·
April 23, 2025
Data from Cohorts 1-3 of trial to be presented in an oral session and poster at the Society for Investigative Dermatology (SID) 2025 Annual Meeting Company to discuss data on its first quarter 2025 business update conference call and webcast scheduled for …
Aligos Therapeutics Announces Eight Abstracts Accepted for Presentation at the EASL Congress 2025
GlobeNewswire
·
April 23, 2025
SOUTH SAN FRANCISCO, Calif., April 23, 2025 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class therapies for liver and viral diseases, today …
Inotiv, Inc. to Report Fiscal 2025 Second Quarter Financial Results and Host Conference Call on Wednesday, May 7, 2025
GlobeNewswire
·
April 23, 2025
WEST LAFAYETTE, Ind., April 23, 2025 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development services and research …
Zentalis Pharmaceuticals Announces Poster Presentation at 2025 ASCO Annual Meeting
GlobeNewswire
·
April 23, 2025
SAN DIEGO, April 23, 2025 (GLOBE NEWSWIRE) -- Zentalis® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company developing a potentially first-in-class and best-in-class WEE1 inhibitor for patients with ovarian cancer and other …
X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
April 23, 2025
BOSTON, April 23, 2025 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (Nasdaq: XFOR), a company driven to improve the lives of people with rare diseases of the immune system, today announced that, effective on January 31, 2025, the company issued inducement awards …